Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection
2017
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.
1995
The DNA-damage response in human biology and disease
2009 StandoutNature
Dendritic cells as therapeutic vaccines against cancer
2005
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
1990
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
2005
Mucin-1 is expressed on dendritic cells, both in vitro and in vivo
2004
Imaging in the era of molecular oncology
2008 StandoutNature
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Immunolipoplexes: An Efficient, Nonviral Alternative for Transfection of Human Dendritic Cells with Potential for Clinical Vaccination
2005
Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine
1992
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
1998 StandoutNature
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
2008 StandoutNature
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Melanoma–stroma interactions: structural and functional aspects
2002
Cancer vaccines: between the idea and the reality
2003
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Cancer immunotherapy comes of age
2011 StandoutNature
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
2009
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
2014
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
2007 StandoutNobel
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 StandoutNatureNobel
The binding site for C1q on IgG
1988 StandoutNatureNobel
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
1997
Mucins in cancer: protection and control of the cell surface
2003
MUC1, The Renaissance Molecule
2001
Lymphokine gene therapy for cancer
1990
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors
1981
Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide.
1985
Control of the Molecular Orientation of Membrane-Anchored Biomimetic Glycopolymers
2009 StandoutNobel
Current Developments in Cancer Vaccines and Cellular Immunotherapy
2003
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
2006
Serotonin-Mediated Endocytosis of apCAM: an Early Step of Learning-Related Synaptic Growth in Aplysia
1992 StandoutScienceNobel
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Immunoglobulin G: Functional sites
1985
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
1996
Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells
2003
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Endocytosis and the recycling of plasma membrane.
1983 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal
2014
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
CD4 cells can be more efficient at tumor rejection than CD8 cells
2007
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Evidence for synthesis of scrapie prion proteins in the endocytic pathway.
1992 StandoutNobel
Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma
2003
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Interfacing Carbon Nanotubes with Living Cells
2006 StandoutNobel
Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
2002
Presentation of a Viral T Cell Epitope Expressed in the CDR3 Region of a Self Immunoglobulin Molecule
1993 StandoutScienceNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of June Kan‐Mitchell being referenced
Establishment and characterization of primary and metastatic uveal melanoma cell lines
1996
Active-specific immunotherapy for melanoma.
1990
Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma
2004
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide
1998
Evaluation of the Human Choroidal Melanoma Rabbit Model for Studying Microcirculation Patterns with Confocal ICG and Histology
1999
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients
1991
Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
2000
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.
1988
Immunological effects of recombinant interferon-alpha 2 in cancer patients.
1983
Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes.
1989
Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophages
1980
Cytotoxic activity of human pulmonary alveolar macrophages.
1985
Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope
2002
Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape
2005
Human monoclonal antibodies directed against melanoma tumor-associated antigens.
1986
Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
2000